NCT00736749

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

Official Title:

Umbrella Long-Term Follow-Up Protocol

Summary

This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.

Eligibility

Inclusion Criteria:

* The patient must reside in the U.S. on the date of enrollment to ALTE05N1
* All patients and/or their parents or legal guardians must sign a written informed consent
* All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met

Disease(s) and\or Condition(s)

Hematopoietic Cell Transplantation Recipient

Leukemia

Solid Tumor

Primary Purpose
Intervention/Treatment
    • Type: PROCEDURE
    • Name: Assessment of Therapy Complications
    • Description: Complete patient response form and Health Status Update Form
    • Arm Group Labels: Observational (long-term follow-up)
    • Type: OTHER
    • Name: Questionnaire Administration
    • Description: Complete patient response form, Health Status Update Form (called the "Keep in Touch" form), and Quality of Life Questionnaire (PROMIS)
    • Arm Group Labels: Observational (long-term follow-up)
Sponsor
  • Children's Oncology Group